MK-4700-001
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
NeoImmuneTech
Merck Sharp & Dohme LLC
Cedars-Sinai Medical Center
Dana-Farber Cancer Institute
University of California, San Francisco
Seagen Inc.
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Hummingbird Bioscience
Takeda
Merck Sharp & Dohme LLC
Xencor, Inc.
Mayo Clinic
MedSIR
Intensity Therapeutics, Inc.
Dana-Farber Cancer Institute
RAPT Therapeutics, Inc.
Merck Sharp & Dohme LLC
Sellas Life Sciences Group
Eli Lilly and Company
Vincerx Pharma, Inc.
Astellas Pharma Inc
The Methodist Hospital Research Institute
HiberCell, Inc.
Eli Lilly and Company
Celldex Therapeutics
City of Hope Medical Center
G1 Therapeutics, Inc.
Dana-Farber Cancer Institute
Genexine, Inc.
City of Hope Medical Center
Mayo Clinic
Corvus Pharmaceuticals, Inc.
Case Comprehensive Cancer Center
Wake Forest University Health Sciences
Roswell Park Cancer Institute
HiberCell, Inc.
UNC Lineberger Comprehensive Cancer Center
West German Study Group
Fate Therapeutics
Spanish Breast Cancer Research Group
Xencor, Inc.
Evelo Biosciences, Inc.
Azienda Ospedaliero-Universitaria di Modena
Tesaro, Inc.
Memorial Sloan Kettering Cancer Center
University of California, San Francisco
Eisai Inc.